Augustine Therapeutics

📍 Ghent, Belgium🗓 Founded 2019👥 4 employees
Augustine Therapeutics focuses on the discovery and development of innovative medicines to benefit patients suffering from Charcot-Marie-Tooth disease (CMT) and other neuromuscular diseases. The company is rooted in the ground-breaking research at VIB and KU Leuven and supported by V-Bio Ventures, PMV, Advent France Biotechnology and Gemma Frisius Fund.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Augustine Therapeutics founded?
Augustine Therapeutics was founded in 2019.
Where is Augustine Therapeutics based?
Augustine Therapeutics is headquartered in Ghent, Belgium.